The gut microbiome (i.e: the microorganisms present in our intestine)
plays a major role in maintaining our health. In case of dysfunction, the microbiome
is linked to a large number of inflammatory, metabolic, and neurological diseases.
The study of the microbiome opens many perspectives for tomorrow’s medicine.
For a decade, the intestinal microbiome has generated increasing interest, as
evidenced by the growing number of scientific publications associated with the
These results pave the way to many perspectives for tomorrow’s medicine in
nutrition, diagnosis, personalized care and explain the growing interest and
investments in the microbiome field by health and nutrition companies as well as
Unfortunately, current methods of sampling the human intestinal microbiome are limited:
- Animal models are difficult to transpose to humans
- Faecal analysis, most commonly used and simple to implement, does not allow a
representative analysis of the in-situ microbiome
- Endoscopy is expensive, invasive and is complex to carry out on a large scale
NEWSPelican Health i-Lab 2021 award recipient!
Organized by the Ministry of Higher Education, Research and Innovation in partnership with Bpifrance i-Lab promotes the results of public research through the creation of innovative technology companies.
This is a great step for Pelican Health with which we will be able to accelerate the development and clinical trials of our non-invasive solution for in-situ sampling of intestinal microbiome. Together, we will be able to offer a new tool for the development of nutritional, therapeutic and diagnostic solutions to revolutionize precision medicine.